Related Experiment Video
Updated: Mar 21, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Cardioembolic Stroke and Postmyocardial Infarction Stroke.
Marius Hornung1, Jennifer Franke1, Sameer Gafoor1
1CardioVascular Center Frankfurt, Sankt Katharinen Krankenhaus, Seckbacher Landstrasse 65, 60389 Frankfurt, Germany.
Stroke after acute myocardial infarction (AMI) is rare but serious. Advances in percutaneous coronary intervention and antithrombotic therapies have significantly reduced stroke risk following AMI.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Ischemic stroke is a rare but serious complication following acute myocardial infarction (AMI).
- Left ventricular thrombus formation and atrial fibrillation are key risk factors for stroke post-AMI.
- Treatment trends and secondary prevention strategies influence stroke risk.
Purpose of the Study:
- To analyze the evolving risk of stroke after acute myocardial infarction.
- To understand the impact of treatment trends on stroke incidence post-AMI.
- To evaluate the role of revascularization and antithrombotic therapies in stroke prevention.
Main Methods:
- Review of treatment trends in acute myocardial infarction care.
- Analysis of the incidence of ischemic and hemorrhagic stroke post-AMI.
- Assessment of the impact of percutaneous coronary intervention and antithrombotic therapies.
- Evaluation of secondary prevention strategies including statins and antihypertensives.
Main Results:
- The overall risk of stroke after AMI has significantly decreased.
- Increased use of percutaneous coronary intervention and acute antithrombotic therapies contributes to risk reduction.
- Secondary prevention strategies like statins, antihypertensives, and DAPT have improved outcomes.
- While reducing ischemic stroke, antiplatelet agents may increase hemorrhagic stroke risk.
Conclusions:
- Modern management strategies have substantially lowered stroke risk after AMI.
- Early revascularization and comprehensive antithrombotic therapy are crucial.
- Continued research into balancing antithrombotic therapy is needed to mitigate hemorrhagic risks.
More Related Videos
05:52Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
Published on: November 4, 2021
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Introduction Cardiac Emergencies
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...